Blog
RSS FeedPosted by Michael Wonder on 06 Aug 2019
A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number.
2 August 2019 - Health economists walk a precarious tightrope: their analyses are quantitative and, presumably, emotion-free. But health care ...
Posted by Michael Wonder on 06 Aug 2019
ICER seeks public comment on proposed methods adaptations for assessments of potential cures and other transformative therapies
6 August 2019 - Proposed adaptations help manage increased uncertainty, capture new value dimensions for appraisal committee voting, and adopt a ...
Posted by Michael Wonder on 31 Jul 2019
Patient preferences studies: how NICE aims to make use of them
2 July 2019 - Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific ...
Posted by Michael Wonder on 27 Jul 2019
Stories of patient involvement impact in health technology assessments: a discussion paper
24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...
Posted by Michael Wonder on 10 Jul 2019
New committee brings diverse patient, family, and caregiver voices to CADTH
10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...
Posted by Michael Wonder on 01 Jul 2019
Ethical challenges related to patient involvement in health technology assessment
28 June 2019 - Including information and values from patients in HTA has the potential to improve both the process and ...
Posted by Michael Wonder on 06 Jun 2019
CMS seeks public input on patients over paperwork initiative to further reduce administrative, regulatory burden to lower health care costs
6 June 2019 - Public feedback will shape initiative’s next steps and future progress in tackling unnecessary burden on healthcare providers. ...
Posted by Michael Wonder on 28 Mar 2019
Keeping up the PACE at the Scottish Medicines Consortium
26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...
Posted by Michael Wonder on 15 Feb 2019
Whether the TGA should publish that a prescription medicine is under evaluation
15 February 2019 - The TGA is seeking comments from interested parties on whether or not the TGA should in future ...
Posted by Michael Wonder on 14 Feb 2019
NICE provides first scientific advice on patient preference study design
14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...
Posted by Michael Wonder on 05 Feb 2019
Risk classification of antimicrobials used in animals opens for public consultation
5 February 2019 - EMA has published today for public consultation its updated scientific advice on the categorisation of antimicrobials. ...
Posted by Michael Wonder on 18 Jan 2019
Patient groups fail to declare financial interests during NICE assessments
16 January 2019 - Patients’ groups involved in assessing treatments for the NHS often fail to disclose their financial interests, ...
Posted by Michael Wonder on 07 Dec 2018
Proposal to list a new presentation of raltegravir and amend arrangements for raltegravir and posaconazole
7 December 2018 - PHARMAC is seeking feedback on a multi-product proposal with Merck Sharpe & Dohme. ...
Posted by Michael Wonder on 15 Nov 2018
EMA seeks feedback on using registries for regulatory purposes
15 November 2018 - The EMA is seeking feedback on the use of patient disease registries for regulatory purposes. ...
Posted by Michael Wonder on 31 Oct 2018
Working with stakeholders to improve availability of medicines in the EU
31 October 2018 - The task force set up by EMA and the Heads of Medicines Agencies on availability of ...